The Latest Trading Price of Sadhana Nitro Chem Ltd is ₹ 1.47 as of 20 Mar 15:30
. The P/E Ratio of Sadhana Nitro Chem Ltd changed from 22.5 on March 2021 to 73.5 on March 2025 . This represents a CAGR of 26.71% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of Sadhana Nitro Chem Ltd changed from ₹ 357.7 crore on March 2021 to ₹ 557.03 crore on March 2025 . This represents a CAGR of 9.26% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of Sadhana Nitro Chem Ltd for the Dec '25 is ₹ 10.96 crore as compare to the Sep '25 revenue of ₹ 2.23 crore. This represent the growth of 391.48% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Sadhana Nitro Chem Ltd for the Dec '25 is ₹ -13.99 crore as compare to the Sep '25 ebitda of ₹ -17.45 crore. This represent the decline of -19.83% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Sadhana Nitro Chem Ltd changed from ₹ 0.62 crore to ₹ -25.14 crore over 7 quarters. This represents a CAGR of NaN%
The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17%
The Dividend Payout of Sadhana Nitro Chem Ltd changed from 50.67 % on March 2022 to 63.1 % on March 2025 . This represents a CAGR of 5.64% over 4 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .
About Sadhana Nitro Chem Ltd
Sadhana Nitro Chem Limited was incorporated on July 21, 1973.
The Company is engaged in manufacturing of chemical intermediates,
heavy organic chemicals and performance chemicals and wireless network equipment and services.
The company has set up a plant for manufacturing meta amino phenol (MAP) with a capacity of 500 tpa with technical know-how from Biazzi, Switzerland.
As on 31st March, 2025 Manekchand Panachand Trading Investment Company Pvt Ltd, holding company owned 61.10 % of the Company's equity share capital.
The company went public in Aug. '93 with a issue of 3.98 lac equity shares of Rs 10 each, aggregating Rs 199.06 lac, to part-finance its diversification project for the manufacture of meta amino phenol (MAP) with the technical know-how from Biazzi, Switzerland.
It has a well-knit market network in countries like the UK the US, Europe, Japan, Korea, and South-East Asian countries.
About Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani.
The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).
FAQs for the comparison of Sadhana Nitro Chem Ltd and Tatva Chintan Pharma Chem Ltd
Which company has a larger market capitalization, Sadhana Nitro Chem Ltd or Tatva Chintan Pharma Chem Ltd?
Market cap of Sadhana Nitro Chem Ltd is 435 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,637 Cr
What are the key factors driving the stock performance of Sadhana Nitro Chem Ltd and Tatva Chintan Pharma Chem Ltd?
The stock performance of Sadhana Nitro Chem Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Sadhana Nitro Chem Ltd and Tatva Chintan Pharma Chem Ltd?
As of March 23, 2026, the Sadhana Nitro Chem Ltd stock price is INR ₹1.47. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1127.45.
How do dividend payouts of Sadhana Nitro Chem Ltd and Tatva Chintan Pharma Chem Ltd compare?
To compare the dividend payouts of Sadhana Nitro Chem Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.